A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research

被引:105
作者
Varadhan, Ravi [1 ,2 ,5 ]
Segal, Jodi B. [1 ,3 ]
Boyd, Cynthia M. [1 ,3 ]
Wu, Albert W. [1 ,3 ]
Weiss, Carlos O. [1 ,4 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21224 USA
[4] Michigan State Univ, Coll Human Med, Dept Family Med, E Lansing, MI 49503 USA
[5] Johns Hopkins Univ, Ctr Aging & Hlth, Baltimore, MD 21205 USA
基金
美国医疗保健研究与质量局;
关键词
Subgroup analysis; Comparative effectiveness research; Prediction; Meta-analysis; Clinical trials; Observational studies; TRIALS;
D O I
10.1016/j.jclinepi.2013.02.009
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Individuals vary in their response to a treatment. Understanding this heterogeneity of treatment effect is critical for evaluating how well a treatment can be expected to work for an individual or a subgroup of individuals. An overemphasis on hypothesis testing has resulted in a dichotomy of all heterogeneity of treatment effect analyses into confirmatory (hypothesis testing) and exploratory (hypothesis finding) analyses. This limited view of heterogeneity of treatment effect is inadequate for creating evidence that is useful for informing patient-centered decisions. An expanded framework for heterogeneity of treatment effect assessment is proposed. It recognizes four distinct goals of heterogeneity of treatment effect analyses: hypothesis testing, hypothesis finding, reporting subgroup effects for meta-analysis, and individual-level prediction. Accordingly, two new types of heterogeneity of treatment effect analyses are proposed: descriptive and predictive. Descriptive heterogeneity of treatment effect analyses report treatment effects for prespecified subgroups in accordance with prospectively specified analytic strategy. They need not be powered to detect heterogeneity of treatment effect. They emphasize estimation and reporting of subgroup effects rather than hypothesis testing. Sampling properties (e.g., standard error) of descriptive analysis can be characterized, thus facilitating meta-analysis of subgroup effects. Predictive heterogeneity of treatment effect analyses estimate probabilities of beneficial and adverse responses of individuals to treatments and facilitates optimal treatment decisions for different types of individuals. Procedures are also suggested to improve reliability of heterogeneity of treatment effect assessment from observational studies. Heterogeneity of treatment effect analysis should be identified as confirmatory, descriptive, exploratory, or predictive analysis. Evidence should be interpreted in a manner consistent with the analytic goal. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:818 / 825
页数:8
相关论文
共 27 条
  • [1] Agency for Healthcare Research and Quality, HLTH CAR PRIOR POP I
  • [2] Alderman EL, 1996, NEW ENGL J MED, V335, P217
  • [3] Journal to encourage analysis by sex/ethnicity
    Arnold, K
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (19) : 1561 - 1561
  • [4] Statistical modeling: The two cultures
    Breiman, L
    [J]. STATISTICAL SCIENCE, 2001, 16 (03) : 199 - 215
  • [6] WHY DATA-BASES SHOULD NOT REPLACE RANDOMIZED CLINICAL-TRIALS
    BYAR, DP
    [J]. BIOMETRICS, 1980, 36 (02) : 337 - 342
  • [7] Analysis of randomized comparative clinical trial data for personalized treatment selections
    Cai, Tianxi
    Tian, Lu
    Wong, Peggy H.
    Wei, L. J.
    [J]. BIOSTATISTICS, 2011, 12 (02) : 270 - 282
  • [8] A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
    Cohn, JN
    Tognoni, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) : 1667 - 1675
  • [9] Estimating treatment effects for individual patients based on the results of randomised clinical trials
    Dorresteijn, Johannes A. N.
    Visseren, Frank L. J.
    Ridker, Paul M.
    Wassink, Annemarie M. J.
    Paynter, Nina P.
    Steyerberg, Ewout W.
    van der Graaf, Yolanda
    Cook, Nancy R.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [10] Assessing Heterogeneity of Treatment Effects: Are Authors Misinterpreting Their Results?
    Fernandez y Garcia, Erik
    Nguyen, Hien
    Duan, Naihua
    Gabler, Nicole B.
    Kravitz, Richard L.
    [J]. HEALTH SERVICES RESEARCH, 2010, 45 (01) : 283 - 301